Login / Signup

Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.

Iain C MacdougallPiotr PonikowskiAustin G StackDavid C WheelerStefan D AnkerJaved ButlerGerasimos S FilippatosUdo-Michael GöhringBridget-Anne KirwanVasuki KumpesonMarco MetraGiuseppe RosanoFrank RuschitzkaPeter van der MeerSandra WächterEwa A Jankowska
Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)
In a cohort of patients with acute heart failure, left ventricular ejection fraction <50%, and iron deficiency, the safety and efficacy of ferric carboxymaltose were consistent across a range of eGFR values.
Keyphrases